This report researches and evaluates the impact of COVID-19 outbreak on the market, including potential opportunities and challenges, drivers, and risks associated with the market. We present a detailed assessment of market growth based on numerous scenarios.

Market Overview:

The market report offers a detailed analysis of the market size, country-level market size, segmentation, market growth, market share, competitive landscape, and the impact of the leading players.

Market Drivers:

The major factors impacting the growth of the Egypt Ventricular Assist Device market size includes the increasing number of patients waiting for heart transplantation, rising number of cases of heart failures, and the shortage of suitable donor organs, which is propelling the demand for alternative approaches particularly in VADs.

On the basis of the application, Bridge-to-recovery (BTR) Therapy segment exhibit the highest growth rate due to the increased government funding, coupled with ongoing research which is supporting the growth of the ventricular assist devices. According to the Egypt Ventricular Assist Device market report, the Bridge-to-transplant (BTT) Therapy segment is responsible for the expansion of the market share in terms of revenue.

Based on the design, the Implantable design segment is predicted to witness a higher CAGR during the forecast period due to the lower rate of thrombosis and the growing concern towards health issues. Transcutaneous design type is projected to have strong demand as it is based on the latest technology with no thrombosis rate.

Market Segmentation:

The Egypt Ventricular Assist Device Market is split by Type, Design, and Application. For the forecast period, the growth among the segments provides accurate calculations and forecasts for sales by different segments in terms of volume and value. This analysis will help in expanding the business by targeting qualified niche markets.

Segment by Type:

Left Ventricular Assist Device
Right Ventricular Assist Device
Biventricular Assist Device
Segment by Design:

Implantable Ventricular Assist Device
Transcutaneous Ventricular Assist Device
Segment by Application:

Bridge-to-transplant (BTT)
Bridge-to-recovery (BTR)
Destination Therapy
Competitive Landscape and Analysis:

The Egypt Ventricular Assist Device Market offers detailed information, including company overview, company total revenue, market potential, and total revenue generated. The report will also provide market share, production sites, SWOT analysis, product launch, and other relevant data.

The key players for the Egypt Ventricular Assist Device Market are Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Abbott, Sun Medical Technology Research Corp., Reliant Heart, Inc., Syncardia System, Inc., Thoratec Corporation , Syncardia System, Inc., and Abiomed, among others.

About GMI Research

GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that is why our analyst uses a tailored methodology to study every market in detail because one size does not fit all. We not only cover the traditional well-established market but also focuses on the niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.

Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to helping businesses stay ahead of the curve.

Visit us: https://www.gmiresearch.com/report/egypt-ventricular-assist-device-vad-market/